Table 1. Projected costs with different strategies of CD4 monitoring in routine care for the estimated 270,000 HIV-infected patients on suppressive ART in the US.
Annual costsa | Lifetime costsa projected for LE 22 years | Lifetime costsa projected for LE 34 years | ||||
---|---|---|---|---|---|---|
|
||||||
Frequency (months) | CD4 Test Cost | CD4 Test Cost | CD4 Test Cost | |||
$38 | $67 | $38 | $67 | $38 | $67 | |
Every 3 | 41.0 | 72.4 | 902.9 | 1591.9 | 1395.4 | 2460.2 |
Every 6b | 20.5 | 36.2 | 451.4 | 796.0 | 697.7 | 1230.1 |
Every 12 | 10.3 | 18.1 | 225.7 | 398.0 | 348.8 | 615.1 |
Abbreviations: HIV, Human Immunodeficiency Virus; ART, antiretroviral therapy;US, United States; LE, life expectancy.
All costs in US$ (millions).
Assumed current standard of care.